Galapagos and Servier Form Multiyear Cancer Therapeutics Partnership
By Heather Cartwright
Pharma Deals Review: Vol 2011 Issue 10 (Table of Contents)
Published: 17 Oct-2011
DOI: 10.3833/pdr.v2011.i10.1588 ISSN: 1756-7874
Section: Research & Development
Fulltext:
Abstract
Servier and Galapagos have entered into a multiyear alliance that is potentially worth more than €260 M (US$348 M) to discover and develop new small molecule cancer therapies...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018